Standout Papers

Liraglutide and Cardiovascular Outcomes in Type 2 ... 2007 2026 2013 2019 4.7k
  1. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes (2016)
    Steven P. Marso, Gilbert H. Daniels et al. New England Journal of Medicine
  2. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes (2007)
    Steven E. Nissen, Kathy Wolski New England Journal of Medicine
  3. Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes (2013)
    William B. White, Christopher P. Cannon et al. New England Journal of Medicine
  4. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes (2017)
    Philip R. Schauer, Deepak L. Bhatt et al. New England Journal of Medicine
  5. Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with Diabetes (2012)
    Philip R. Schauer, Sangeeta R. Kashyap et al. New England Journal of Medicine
  6. Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes (2014)
    Philip R. Schauer, Deepak L. Bhatt et al. New England Journal of Medicine
  7. Effect of Recombinant ApoA-I Milano on Coronary Atherosclerosis in Patients With Acute Coronary Syndromes (2003)
    Steven E. Nissen, Taro Tsunoda et al. JAMA
  8. Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease (2005)
    Steven E. Nissen, E. Murat Tuzcu et al. New England Journal of Medicine
  9. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. (2007)
    A. Michael Lincoff, Kathy Wolski et al. PubMed
  10. ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org (1999)
    Patrick J. Scanlon, David P. Faxon et al. Journal of the American College of Cardiology
  11. Coronary Plaque Classification With Intravascular Ultrasound Radiofrequency Data Analysis (2002)
    Anuja Nair, Barry D. Kuban et al. Circulation
  12. Prognostic Value of Myeloperoxidase in Patients with Chest Pain (2003)
    Marie‐Luise Brennan, Marc S. Penn et al. New England Journal of Medicine
  13. Effect of Antihypertensive Agents on Cardiovascular Events in Patients With Coronary Disease and Normal Blood Pressure (2004)
    Steven E. Nissen, E. Murat Tuzcu et al. JAMA
  14. Our Preoccupation With Coronary Luminology (1995)
    Eric J. Topol, Steven E. Nissen Circulation
  15. Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes (2008)
    Steven E. Nissen, Stephen J. Nicholls et al. JAMA
  16. Intravascular Ultrasound (2001)
    Steven E. Nissen, Paul G. Yock Circulation
  17. Extent and Direction of Arterial Remodeling in Stable Versus Unstable Coronary Syndromes (2000)
    Paul Schoenhagen, Khaled M. Ziada et al. Circulation
  18. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials (2014)
    Karen A. Hicks, James E. Tcheng et al. Circulation
  19. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials (2014)
    Karen A. Hicks, James E. Tcheng et al. Journal of the American College of Cardiology
  20. Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation (2020)
    Oussama M. Wazni, Gopi Dandamudi et al. New England Journal of Medicine
  21. Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity (2019)
    Ali Aminian, Alexander Zajichek et al. JAMA
  22. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials (2023)
    Paul M. Ridker, Deepak L. Bhatt et al. The Lancet
  23. Association of Cardiorespiratory Fitness With Long-term Mortality Among Adults Undergoing Exercise Treadmill Testing (2018)
    Kyle Mandsager, Serge C. Harb et al. JAMA Network Open
  24. Effect of Evolocumab on Coronary Plaque Phenotype and Burden in Statin-Treated Patients Following Myocardial Infarction (2022)
    Stephen J. Nicholls, Yu Kataoka et al. JACC. Cardiovascular imaging
  25. Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels (2022)
    Steven E. Nissen, Kathy Wolski et al. JAMA
  26. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis (2021)
    Ali Aminian, Abbas Al‐Kurd et al. JAMA
  27. Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity (2022)
    Ali Aminian, Rickesha Wilson et al. JAMA
  28. Myosin Inhibition in Patients With Obstructive Hypertrophic Cardiomyopathy Referred for Septal Reduction Therapy (2022)
    Milind Y. Desai, Anjali Owens et al. Journal of the American College of Cardiology
  29. Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS‐CVOT design and baseline characteristics (2023)
    Stephen J. Nicholls, Deepak L. Bhatt et al. American Heart Journal
  30. Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a) (2023)
    Steven E. Nissen, Helle Linnebjerg et al. JAMA
  31. Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation (2023)
    Stephen J. Nicholls, Steven E. Nissen et al. JAMA
  32. Testosterone Treatment and Fractures in Men with Hypogonadism (2024)
    Peter J. Snyder, Douglas C. Bauer et al. New England Journal of Medicine
  33. Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a) (2024)
    Steven E. Nissen, Kathy Wolski et al. JAMA
  34. Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a) (2024)
    Steven E. Nissen, Qiuqing Wang et al. JAMA
  35. Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension (2025)
    Luke J. Laffin, Branko Kopjar et al. New England Journal of Medicine
  36. Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a) (2025)
    Steven E. Nissen, Wei Ni et al. New England Journal of Medicine

Immediate Impact

4 from Science/Nature 157 standout
Sub-graph 1 of 16

Citing Papers

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
2024 Standout
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2023 Standout
70 intermediate papers

Works of Steven E. Nissen being referenced

Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population
2022
Effect of Naltrexone-Bupropion on Major Adverse Cardiovascular Events in Overweight and Obese Patients With Cardiovascular Risk Factors
2016
and 19 more

Author Peers

Author Last Decade Papers Cites
Steven E. Nissen 18206 11175 5940 14266 389 38.3k
Neil J. Stone 18539 14922 3844 13998 187 44.0k
Marc S. Sabatine 22026 27026 5004 12790 499 49.0k
Darren K. McGuire 10353 13589 1910 24831 456 38.4k
Antonio M. Gotto 26174 11477 2243 16038 588 48.9k
Kalevi Pyörälà 12439 12496 2661 14694 227 33.4k
Mark A. Creager 13964 22309 3601 6852 345 47.1k
Stephen J. Nicholls 16519 8452 4776 8730 663 29.2k
Hans Wedel 14372 21117 1982 14602 265 42.9k
J. Wouter Jukema 16605 12798 7799 6162 881 36.4k
Jacques Genest 15748 12801 1298 10316 704 39.5k

All Works

Loading papers...

Rankless by CCL
2026